New Research Looks at Whether GLP-1 Drugs Are Worth Their High Price

NEW RESEARCHINSURANCE AND ACCESS

Researchers are trying to quantify the long-term health benefits of GLP-1 drugs — like reduced risk of heart disease and diabetes — to determine if their steep cost is justified. The drugs show real promise for improving health outcomes, but those benefits only hold if patients can afford to stay on them long-term, which many cannot.

Source: Nbcnews